Hematology & Clinical Biology
Pappenheimer body
Pappenheimer bodies are small pathological intracytoplasmic granules observed in erythrocytes (mature red blood cells) and erythroblasts on May-Grünwald-Giemsa (MGG)-stained blood smears. They consist of non-heme iron in the form of precipitated ferritin and hemosiderin, trapped within degenerated mitochondria and lysosomes inside the erythrocyte. First described in 1945 by the German physician Alwin Pappenheimer, they appear as tiny irregular basophilic (bluish) granules, 0.5 to 1 µm in diameter, located at the periphery of the erythrocyte cytoplasm, often grouped in clusters of 2 to 5 granules—typically in the marginal region of the cell. They are distinguished by their double positive staining: blue with standard MGG and positive with Prussian blue (a specific dye for ferrous iron—Perls« stain), which confirms them as non-heme iron deposits and distinguishes them from other erythrocyte inclusions (Howell-Jolly bodies, basophilic stippling, Cabot rings). An erythrocyte containing Pappenheimer bodies is called a siderocyte, and when these inclusions are present in erythroid precursors (erythroblasts) in the bone marrow, they are referred to as normal sideroblasts (scattered granules) or ring sideroblasts — when the granules form a complete or subcomplete perinuclear ring, indicating an abnormality in mitochondrial iron utilization characteristic of myelodysplastic syndromes and hereditary sideroblastic anemia). The presence of Pappenheimer bodies on a peripheral blood smear is always pathological and constitutes a major hematological warning sign pointing to two broad diagnostic contexts: erythrocyte iron overload (sideroblastic anemia, hemochromatosis, polytransfusion) or asplenia (functional or anatomical)—the spleen being the organ normally responsible for removing these inclusions from circulating red blood cells through a process of splenic »pitting.”.
Formation mechanism
- Accumulation of unused mitochondrial iron: Under normal conditions, ferrous iron (Fe²⁺) is incorporated into protoporphyrin IX within erythroblast mitochondria to form heme, and then hemoglobin; any defect in this incorporation (abnormality of ferrochelatase or mitochondrial ALA-synthase 2, lead poisoning blocking ferrochelatase, pyridoxine B6 deficiency, ALAS2 or SLC25A38 gene mutations) leads to iron accumulation in mitochondria in the form of precipitated ferritin and hemosiderin—these deposits persist in the mature erythrocyte after expulsion of the erythroblast nucleus.
- Splenic pitting defect: Under physiological conditions, the spleen actively removes pathological inclusions (Howell-Jolly bodies, Pappenheimer bodies, basophilic stippling) from circulating erythrocytes through a mechanical filtration mechanism in the splenic sinusoids. This process, called «pitting,» allows the erythrocyte to pass through the narrow splenic endothelial slits while shedding its rigid inclusions. In the absence of a functional spleen (surgical or functional asplenia), this mechanism is abolished, and erythrocytes laden with inclusions persist in circulation, including Pappenheimer bodies that would normally have been eliminated.
- Systemic martial surcharge: in severe hereditary hemochromatosis, repeated transfusions and intestinal iron hyperabsorption, saturation of iron transfer capacity and overflow into erythrocytes as non-transferrin-bound iron (NTBI) can contribute to the formation of erythrocyte intracytoplasmic iron deposits.
Causes and Clinical Contexts
| Cause | Mechanism, context, and associations |
|---|---|
| Surgical asplenia (splenectomy) | The most frequent cause of Pappenheimer bodies on smears in North America is the disappearance of splenic pitting after splenectomy. Pappenheimer bodies appear within the first few weeks postoperatively, along with Howell-Jolly bodies (which are larger and more visible). They are always associated with other markers of asplenia: Howell-Jolly bodies, acanthocytes, and target cells (ovalocytes). Splenectomy is performed for trauma, immune thrombocytopenic purpura (ITP), and constitutional hemolytic anemias (spherocytosis, sickle cell disease). |
| Functional asplenia | Anatomically present but functionally deficient — sickle cell disease (recurrent splenic infarcts → progressive autosplenectomy from childhood); untreated or refractory celiac disease; systemic lupus erythematosus; splenic amyloidosis; essential thrombocythemia; Fanconi's disease; major congestive splenomegaly (severe portal hypertension) |
| X-linked hereditary sideroblastic anemia (ALAS2) | ALAS2 gene mutation (erythroid ALA synthase 2, X chromosome) — impaired ALA synthesis → impaired iron incorporation into heme → mitochondrial iron accumulation → ringed sideroblasts in the bone marrow (> 15% % erythroblasts); young man, hypochromic microcytic anemia with very high serum iron and ferritin levels; peripheral Pappenheimer bodies; treatment with pyridoxine (vitamin B6) — partial response in some patients (B6-responsive mutation) |
| Myelodysplastic syndromes with ring sideroblasts (MDS-RS) | Somatic mutations in SF3B1 (a component of the splicosome) in >85% of RS-MDS cases — leading to dysregulation of ABCB7 splicing (a mitochondrial iron transporter) → accumulation of perinuclear mitochondrial iron; refractory macrocytic or normocytic anemia in adults over 60 years of age; smear: Pappenheimer bodies, erythrocyte dimorphism (normochromic population + hypochromic population); diagnosis confirmed by bone marrow aspiration with Perls staining (> 15% ringed sideroblasts) |
| Lead poisoning (plumbism) | Lead inhibits ferrochelatase (the last enzyme in heme synthesis) and delta-ALA-dehydratase → accumulation of protoporphyrin and iron in mitochondria; predominantly coarse basophilic stippling (aggregated ribosomes - more distinctive than Pappenheimer bodies in saturnism); moderate microcytic anemia; elevated blood lead levels; elevated red blood cell zinc protoporphyrin (ZPP) |
| Polytransfusions and post-transfusion iron overload | Hemoglobinopathies (thalassemia major, sickle cell disease) requiring repeated transfusions — progressive iron overload; Pappenheimer bodies in the context of iron overload and often associated functional asplenia |
| Severe hemolytic anemia | Massive intravascular hemolysis—release of erythrocyte iron into circulation exceeding transferrin binding capacity → NTBI → deposition in newly formed erythrocytes; sickle cell disease, G6PD deficiency crisis, severe autoimmune hemolytic anemia |
| Pyridoxine (vitamin B6) deficiency | Vitamin B6 is an essential cofactor for ALAS2 (erythroid ALA-synthase 2) — the first enzyme in the heme synthesis pathway; severe dietary deficiency, chronic alcoholism, malabsorption, medications (isoniazid, cycloserine, which are B6 antagonists) → acquired sideroblastic anemia reversible with supplementation. |
ℹ️
The distinction between Pappenheimer bodies and Howell-Jolly bodies is clinically important: Howell-Jolly bodies are unique, large (1–2 µm), central or eccentric, DNA-positive (Feulgen), and Prussian blue-negative—they exclusively indicate asplenia. Pappenheimer bodies are multiple, small, peripheral, and Prussian blue (iron)-positive—they indicate either asplenia (often associated with Howell-Jolly bodies) or an iron utilization anomaly (sideroblastic anemia). The coexistence of both inclusions on the same smear is highly suggestive of asplenia with associated dyserythropoiesis.
Diagnosis and assessment
- Peripheral blood smear with MGG staining: reference examination for the identification of Pappenheimer bodies—appearance of small irregular basophilic granules (0.5–1 µm) at the periphery of the cytoplasm, often grouped in clusters of 2 to 5; simultaneous presence of other red blood cell abnormalities suggesting the etiology—Howell-Jolly bodies (asplenia), basophilic stippling (lead poisoning, thalassemia), acanthocytes and target cells (asplenia), schistocytes (microangiopathic hemolysis), red blood cell dimorphism (MDS-RS)
- Perls stain (Prussian blue) on smears or bone marrow: confirms the iron-containing nature of the granulations (bright blue staining); allows for counting the percentage of siderocytes (Perls-positive erythrocytes) and quantifying bone marrow sideroblasts; ringed sideroblasts (> 15 % = diagnostic threshold for MDS-RS and hereditary sideroblastic anemia)
- Comprehensive iron panel: serum ferritin (marker of iron stores—very high in iron overload); serum iron; transferrin saturation (TS—elevated in iron overload: >45%); total transferrin-binding capacity (TTBC); serum transferrin; erythrocyte ferritin (limited availability)
- Red blood cell indices: MCV (mean corpuscular volume) - microcytosis (X-linked hereditary sideroblastic anemia, lead poisoning) or macrocytosis/normocytosis (MDS-RS); MCH (mean corpuscular hemoglobin) - hypochromia; reticulocytes; leukocytes and platelets (pancytopenia in MDS)
- Myelogram with bone marrow biopsy: indicated if MDS-RS, hereditary sideroblastic anemia, or suspected malignant hemopathy — bone marrow cytology with Prussian blue stain (ring sideroblasts), bone marrow karyotype, molecular biology (SF3B1 mutation, JAK2, CALR, ALAS2 mutations)
- Assessment of asplenia: abdominal ultrasound (absence or atrophy of the spleen); technetium-99m spleen scan if doubt about functional asplenia (absence of uptake = functional asplenia confirmed); proportion of Howell-Jolly bodies and acanthocytes as a complement to the blood smear.
- Assessment guided by context: blood lead level and zinc protoporphyrin if lead poisoning is suspected (occupation, age, old housing); vitamin B6 if deficiency is suspected (alcoholism, malabsorption, isoniazid); direct Coombs test, LDH, haptoglobin, indirect bilirubin if hemolysis; genetic panel (ALAS2, SLC25A38, GLRX5) if young-onset hereditary sideroblastic anemia
Clinical significance and treatment
- Isolated Pappenheimer bodies with Howell-Jolly bodies on blood smear (without significant anemia): primarily suggest asplenia — check for history of splenectomy or autoimmune splenic pathology (sickle cell disease, celiac disease); asplenia requires anti-infective prophylaxis (vaccination against pneumococcus, meningococcus, Haemophilus influenzae b and antibiotic prophylaxis according to recommendations) and increased vigilance for any febrile episode (overwhelming post-splenectomy infection — OPSI sepsis).
- Pappenheimer bodies with hypochromic microcytic anemia and high serum iron (paradox: low iron in erythrocytes but high in blood): suggest hereditary sideroblastic anemia (young male) or acquired (adult, medication) — bone marrow aspirate with systematic Perls stain; therapeutic trial of vitamin B6 (100 mg/day × 3 months) before bone marrow aspirate in moderate, slowly progressing forms
- Pappenheimer bodies with normocytic or macrocytic anemia, dimorphism, and pancytopenia in adults over 60 years of age: consider myelodysplastic syndrome with ring sideroblasts (MDS-RS) — myelogram, cytogenetics, and molecular biology (SF3B1); mandatory hematological referral
- Pappenheimer bodies with basophilic stippling and mild anemia: suspect lead poisoning (lead) — measure blood lead level urgently if occupational or environmental exposure context; chelation therapy if blood lead level is above action thresholds
- Any smear showing Pappenheimer bodies should trigger a complete medical interpretation in the clinical context—they are not a trivial finding, and their presence should always lead to the identification of the underlying cause.
Asplenia and infectious risk — absolute vigilance
In any asplenic patient (surgically or functionally) presenting with Pappenheimer bodies and Howell-Jolly bodies on their smear, any febrile episode (> 38.5 °C) must be considered a medical emergency — risk of overwhelming post-splenectomy infection (OPSI) by encapsulated bacteria.Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae) which can progress to septic shock and death within 24 hours. Consult a doctor immediately or dial 911 before any febrile episode in an asplenic patient, particularly if pneumococcal and meningococcal vaccination is not up to date.
Consult at Clinique Omicron
Clinique Omicron physicians interpret abnormal blood smears reported by the laboratory, prescribe iron overload and asplenia workups, refer to the hematologist for suspected myelodysplastic syndrome or hereditary sideroblastic anemia, and provide preventive follow-up for asplenic patients (vaccination, antibiotic prophylaxis). Consultations are available at our Quebec branches and via telemedicine throughout the province. To book an appointment, visit cliniqueomicron.ca.
The content of this page is for informational purposes only and does not substitute for the advice of a qualified healthcare professional. The presence of Pappenheimer bodies on a blood smear requires specialized medical interpretation to identify the underlying cause.
Omicron Clinic
Need to consult a doctor?
Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.
Insurance receipts. 7j/7. No family doctor required.